← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Assuage Pharmaceuticals, Inc.
Palm City, FL
$1,372,119
Total funding
3
Grants
Funding over time
peak $730.8K · FY2014–16$1M$750K$500K$250K$0
'14
'15
'16
Funding mix
By agency
NIH$1,372,119 · 3
By mechanism
R44$997,167 · 1
R41$224,956 · 1
R43$149,996 · 1
Investigators at Assuage Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation$500,849
R44 · FY2016 · DA
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation$491,318
R44 · FY2015 · DA
Discovery of alpha4beta2 Nicotinic Receptor Antagonists as Alcohol Abuse Medications$224,956
R41 · FY2016 · AA
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation$149,996
R43 · FY2014 · DA
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation$5,000
R44 · FY2016 · DA